Sara Lonardi

Ontology type: schema:Person     

Person Info





Publications in SciGraph latest 50 shown

  • 2019-02 Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies in DRUG SAFETY
  • 2019-02 Safety and Tolerability of c-MET Inhibitors in Cancer in DRUG SAFETY
  • 2018-12 Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases in CANCER CELL INTERNATIONAL
  • 2018-12 The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients in BMC CANCER
  • 2018-09 Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer in THE PHARMACOGENOMICS JOURNAL
  • 2018-08 Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patients in INVESTIGATIONAL NEW DRUGS
  • 2018-06 Correction: The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients in BRITISH JOURNAL OF CANCER
  • 2018-04 Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials in BRITISH JOURNAL OF CANCER
  • 2018-04 Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study in TARGETED ONCOLOGY
  • 2017-12 TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group in BMC CANCER
  • 2017-10-24 Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients in BRITISH JOURNAL OF CANCER
  • 2017-10-10 First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial in BRITISH JOURNAL OF CANCER
  • 2017-09 Exposure–response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2017-08 Rectal sparing approach after preoperative radio- and/or chemotherapy (RESARCH) in patients with rectal cancer: a multicentre observational study in TECHNIQUES IN COLOPROCTOLOGY
  • 2017-03 An untreatable dyspnoea: more defendants under investigation in INTERNAL AND EMERGENCY MEDICINE
  • 2016-05 Development of an oncological-multidimensional prognostic index (Onco-MPI) for mortality prediction in older cancer patients in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2015-12 Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data in JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
  • 2015-11 Assessment of a HER2 scoring system for colorectal cancer: results from a validation study in MODERN PATHOLOGY
  • 2015-10 Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis in WORLD JOURNAL OF SURGERY
  • 2015-06 BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection in BRITISH JOURNAL OF CANCER
  • 2015-06 MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin in THE PHARMACOGENOMICS JOURNAL
  • 2015-05 Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients in SCIENTIFIC REPORTS
  • 2014-07 Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab in BRITISH JOURNAL OF CANCER
  • 2014-04 Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer in BRITISH JOURNAL OF CANCER
  • 2013-10 A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen in THE PHARMACOGENOMICS JOURNAL
  • 2013-02 Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer in BRITISH JOURNAL OF CANCER
  • 2012-12 Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2012-09 Telomere-Specific Reverse Transcriptase (hTERT) and Cell-free RNA in Plasma as Predictors of Pathologic Tumor Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy in ANNALS OF SURGICAL ONCOLOGY
  • 2012-08 Significance of pulmonary nodules in patients with colorectal cancer in EUROPEAN RADIOLOGY
  • 2012-01 Hepatoid Adenocarcinoma of the Colon: What Should We Target? in PATHOLOGY & ONCOLOGY RESEARCH
  • 2011-10 Cancer in the elderly in INTERNAL AND EMERGENCY MEDICINE
  • 2011-09 Circulating Cell-Free DNA: A Promising Marker of Pathologic Tumor Response in Rectal Cancer Patients Receiving Preoperative Chemoradiotherapy in ANNALS OF SURGICAL ONCOLOGY
  • 2010-05 Health-related quality of life, faecal continence and bowel function in rectal cancer patients after chemoradiotherapy followed by radical surgery in SUPPORTIVE CARE IN CANCER
  • 2009-04 Long-Term Oncologic Results and Complications After Preoperative Chemoradiotherapy for Rectal Cancer: A Single-Institution Experience After a Median Follow-Up of 95 Months in ANNALS OF SURGICAL ONCOLOGY
  • 2007-05 Oral Anticancer Drugs in the Elderly in DRUGS & AGING
  • 2007-04 Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO) in BRITISH JOURNAL OF CANCER
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

        "@context": "", 
        "affiliation": [
            "affiliation": {
              "id": "", 
              "type": "Organization"
            "isCurrent": true, 
            "type": "OrganizationRole"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
        "familyName": "Lonardi", 
        "givenName": "Sara", 
        "id": "sg:person.01155122733.59", 
        "identifier": {
          "name": "orcid_id", 
          "type": "PropertyValue", 
          "value": [
        "sameAs": [
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:54", 
        "sdLicense": "", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_627.json", 
        "type": "Person"

    Download the RDF metadata as:  json-ld nt turtle xml License info


    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' ''

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' ''

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' ''

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' ''


    This table displays all metadata directly associated to this object as RDF triples.

    29 TRIPLES      11 PREDICATES      17 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01155122733.59 schema:affiliation N363583918a7c4cd091800f2034de94a5
    6 schema:familyName Lonardi
    7 schema:givenName Sara
    8 schema:identifier Nffc5fc21f2f443748edbcc3814696803
    9 schema:sameAs
    11 schema:sdDatePublished 2019-03-07T14:54
    12 schema:sdLicense
    13 schema:sdPublisher Nbc1caf6f710c46a7ba12a6080d36d631
    14 sgo:license sg:explorer/license/
    15 sgo:sdDataset persons
    16 rdf:type schema:Person
    17 N363583918a7c4cd091800f2034de94a5 schema:affiliation
    18 sgo:isCurrent true
    19 rdf:type schema:OrganizationRole
    20 Nbc1caf6f710c46a7ba12a6080d36d631 schema:name Springer Nature - SN SciGraph project
    21 rdf:type schema:Organization
    22 Nffc5fc21f2f443748edbcc3814696803 schema:name orcid_id
    23 schema:value 0000-0002-7593-8138
    24 rdf:type schema:PropertyValue
    25 schema:Organization
    26 schema:Organization
    27 schema:Organization
    28 schema:Organization
    29 schema:Organization

    Preview window. Press ESC to close (or click here)